This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vigeneron Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Christian Schön: Innovator in AAV Vector Technology
Introduction
Christian Schön is a notable inventor based in Mietingen, Germany. He has made significant contributions to the field of gene therapy, particularly through his work on adeno-associated virus (AAV) vectors. His innovative approach has the potential to advance medical treatments and improve patient outcomes.
Latest Patents
Christian Schön holds a patent related to AAV vectors. The patent describes an adeno-associated virus that includes an insertion of at least 6-8 amino acids between specific positions in the viral sequence. This invention not only outlines the structure of the AAV but also envisions its use as a medicament and in pharmaceutical compositions. Furthermore, the patent discusses the in vitro use of the AAV for transducing the nucleus of retinal cells, along with methods for screening insertion sequences and the development of related kits.
Career Highlights
Christian Schön is associated with Vigeneron GmbH, where he continues to push the boundaries of gene therapy research. His work has garnered attention for its innovative applications and potential therapeutic benefits.
Collaborations
Some of his notable coworkers include Martin Biel and Hildegard Büning, who contribute to the collaborative environment at Vigeneron GmbH.
Conclusion
Christian Schön's contributions to AAV vector technology exemplify the impact of innovation in the field of gene therapy. His work holds promise for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile